AstraZeneca Plc, the company that manufactures AstraZeneca vaccines, has rubbished claims that the jab is linked to certain cases of deadly blood clots noted in some European countries.

The company said it had conducted a review of 17 million recipients of the vaccine in the European Union and the United Kingdom and had ascertained that there were no leads linking the vaccine to the coagulation.

“A careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” the company said in a statement, as revealed by Reuters.

The drug maker said it would continue conducting the tests to find out the root cause of the problem. But it has also insisted that research studies from European laboratories have revealed not health issues.

Ireland became the latest country to slam brakes on the inoculation using the AstraZeneca vaccine.

Denmark, Norway, Iceland and Austria have all suspended the issuance of their first batch AstraZeneca jabs after cases of deadly coagulation were noted.